For the Inventor, By the Inventor

Enter assignee name

Wokingham, United Kingdom

Vernalis Research Limited

Calculating rank

USPTO Granted Patents = 43

% Expired Patents = 76.7

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 262

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

David Reginald Adams (20 out of 20 patents)

Roger John Gillespie (16 out of 25 patents)

Howard Langham Mansell (15 out of 16 patents)

4. Jonathan Richard Anthony Roffey (14 out of 14 patents)

5. Joanne Lerpiniere (12 out of 12 patents)

6. James Edward Paul Davidson (12 out of 13 patents)

7. Suneel Gaur (11 out of 11 patents)

8. Richard John Hamlyn (11 out of 11 patents)

9. Jonathan Mark Bentley (10 out of 13 patents)

10. Claire Elizabeth Dawson (8 out of 8 patents)

11. Stephan Roever (7 out of 56 patents)

12. Nathaniel Monck (7 out of 7 patents)

13. Ian Anthony Cliffe (7 out of 7 patents)

14. Paul Hebeisen (6 out of 49 patents)

15. Robert Mark Pratt (6 out of 6 patents)

Core Competencies:

Purinergic Receptor Antagonists

5HT2C Agonists

CNS Disorders

Obesity Treatments

Indole Derivatives

Azetidinecarboxamide

Pyrimidine Derivatives

Triazole Derivatives

Morpholine Derivatives

Anti-Obesity Compounds

Glutamatergic Transmission

Hexahydropyrazinoindoles

43 patents: Sort by Forward Citations

1. 7629349 - Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists (2009-12-08),

2. 7598256 - Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists (2009-10-06),

3. 7589097 - Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists (2009-09-15),

4. 7547699 - Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity (2009-06-16),

5. 7504522 - Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders (2009-03-17),

6. 7452894 - Purine derivatives as purinergic receptor antagonists (2008-11-18),

7. 7405219 - Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists (2008-07-29),

8. 7384949 - Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists (2008-06-10),

9. 7323487 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2008-01-29),

10. 7323486 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2008-01-29),

11. 7323473 - [object Object] (2008-01-29),

12. 7323466 - Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity (2008-01-29),

13. 7253281 - Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles (2007-08-07),

14. 7208494 - 5HT2c receptor agonists (2007-04-24),

15. 7173056 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2007-02-06),

Company Overview

Vernalis Research Limited, based in Wokingham, GB, specializes in the development of innovative therapeutic solutions targeting various central nervous system disorders. The company focuses on purinergic receptor antagonists and 5HT2C receptor agonists, among other compounds, to address obesity and related health issues. With a strong emphasis on research in glutamatergic transmission and receptor modulation, Vernalis is committed to advancing treatments that improve patient outcomes in complex neurological conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

43 Patents

#1 in Wokingham

#406 in United Kingdom

#16,053 in the World

Wokingham, United Kingdom

Vernalis Research Limited

Forward Citations = 262

55 inventors:

David Reginald Adams (20 out of 20 patents)

Roger John Gillespie (16 out of 25 patents)

Howard Langham Mansell (15 out of 16 patents)

4. Jonathan Richard Anthony Roffey (14 out of 14 patents)

5. Joanne Lerpiniere (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vernalis Research Limited. Retrieved from https://idiyas.com/company/vernalis-research

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…